Table 1. Age standardized incidence rates and Joinpoint analyses for 2002 to 2015 in Uruguay. Women.
Standardized incidence rate (per 100.000 person-year) | Period | APC | APC 95% CI | |||
---|---|---|---|---|---|---|
2002 | 2015 | |||||
Esophagus (C15) | 3.0 | 1.7 | 2002 | 2015 | -3.7* | -5.4;-2.0 |
Stomach (C16) | 6.7 | 5.5 | 2002 | 2015 | -1.7* | -2.8;-0.5 |
Colorectum(C18-C21) | 24.9 | 27.5 | 2002 | 2015 | 0.3 | -0.3;1.0 |
Lung (C33-C34) | 8.7 | 14.0 | 2002 | 2015 | 3.3* | 2.3;4.3 |
Kidney (C64-C65) | 6.0 | 7.8 | 2002 | 2015 | 2.8* | 1.4;4.2 |
Urothelial (C66-C68) | 3.0 | 2.5 | 2002 | 2015 | -0.4 | -2.5;1.8 |
Thyroid (C73) | 4.7 | 14.6 | 2002 | 2015 | 8.7* | 6.7;10.8 |
Breast (C50) | 77.3 | 71.1 | 2002 | 2015 | -0.3 | -0.9;0.2 |
Cervix (C53) | 17.6 | 14.8 | 2002 | 2005 | 2.4 | -4.4;9.7 |
2005 | 2010 | -5.1* | -9.3;-0.7 | |||
2010 | 2015 | 0.0 | -3.3;3.3 | |||
ACS† | 228.6 | 232.3 | 2002 | 2015 | 0.0 | -0.4;0.4 |
†All cancer sites (excluding non melanoma of skin)* The estimated annual percent change is significantly different from 0 (two-side p <0.05); APC: annual percentage change